ST. PAUL, Minn.--(BUSINESS WIRE)--Transoma Medical, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission in connection with a proposed initial public offering of its common stock. Piper Jaffray & Co. is acting as sole book-running manager, Thomas Weisel Partners LLC is acting as joint-lead manager, and RBC Capital Markets, Canaccord Adams Inc. and BMO Capital Markets are acting as co-managers for this offering. The number of shares to be offered and the price range for the offering have not yet been determined. The proposed offering will include shares sold by Transoma and by certain of its stockholders.
